A nurse stands beside an older dialysis patient, explaining his treatment with warmth
The crisis & the opportunity

Kidney disease is quietly becoming a national emergency.

The numbers are stark — and they describe an infrastructure failure, not a market failure. Demand is funded. Capacity is not.

The disease

One in nine Filipinos already lives with it.

12.94M
Filipinos with chronic kidney disease — roughly 11.2% of the population
1 / hour
A new case of kidney failure — about 120 per million people, every year
60.9%
Of cases are diabetes-driven — and the share keeps growing
The treatment reality

For 94 in 100, the chair is life itself.

94% of patients depend on center-based hemodialysis for life. Only 2% ever reach transplant — the gold-standard cure.

The economic weight is national: ₱592B in total annual CKD burden, ₱147B of it in dialysis and end-stage care.

94%
Depend on center-based hemodialysis for life
2%
Ever reach a transplant
592B
Total annual CKD economic burden
147B
Of it in dialysis and end-stage care
The market gap

Demand has outrun the chairs.

~875
Dialysis centers nationwide
~10,500
Chairs installed
~63,000
Patients serviceable — vs ~80,000 in need
15.5% / yr
Growth in PhilHealth HD claims — 5.1M claims in 2024
Where the gap is widest

Capacity clusters in the cities. The provinces are left behind.

Center counts tell the story: care concentrates where it's easiest to build, not where patients are. That's where we deploy — where PhilHealth funding is identical and competition is thin.

Luzon436 centers
NCR218 centers
Visayas115 centers
Mindanao106 centers
The tailwind

Recurring, predictable, government-funded.

Revenue depends on capacity, not patient affordability.

₱6,350 per session

Funded under PhilHealth Circular 2024-0023 — up to ₱990,600 per patient, per year.

No Balance Billing

Patients aren't asked to cover the gap — sessions are paid in full at accredited centers.

Universal Health Care Act

The funding is law, not policy whim — dialysis coverage is backed by national legislation.

Sources: Journal of Medical Economics 2025 · Lancet Regional Health Western Pacific · PhilHealth · Ken Research · NKTI.